Unlocking the genetics of skin cancer
Nov 12, 2024 ·
11m 4s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Dr https://www.sanger.ac.uk/person/adams-david/, Senior Group Leader at the Wellcome Sanger Institute, is a pioneer in cancer biology and uncovering skin cancer genetics. We explore his 20-year career at Sanger and the...
show more
Dr David Adams, Senior Group Leader at the Wellcome Sanger Institute, is a pioneer in cancer biology and uncovering skin cancer genetics. We explore his 20-year career at Sanger and the global impact of his research.
Melanoma is the fifth most common cancer in the UK, and while treatments have progressed in recent years, it is still the deadliest form of skin cancer. Dave Adams leads a team at the Sanger Institute that study a range of cancer types, with a focus on melanoma. His work has created a foundational understanding of cancer genetics and the results hold promise for new treatments. Dave has recently been promoted to Interim Head of the Cancer, Ageing and Somatic Mutation research programme at the Sanger Institute.
show less
Melanoma is the fifth most common cancer in the UK, and while treatments have progressed in recent years, it is still the deadliest form of skin cancer. Dave Adams leads a team at the Sanger Institute that study a range of cancer types, with a focus on melanoma. His work has created a foundational understanding of cancer genetics and the results hold promise for new treatments. Dave has recently been promoted to Interim Head of the Cancer, Ageing and Somatic Mutation research programme at the Sanger Institute.
Information
| Author | Wellcome Sanger Institute |
| Organization | Wellcome Sanger Institute |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
